This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

reputable news agency


Mailed human papillomavirus self-sampling kits are cost-effective

Mailed human papillomavirus self-sampling kits are cost-effective

Mailing human papillomavirus (HPV) self-sampling kits is an efficient outreach strategy for increasing screening rates among women overdue for screening, according to a study published online March 22 in JAMA Network Open.

Richard T. Meenan, Ph.D., from Kaiser Permanente Northwest in Portland, Oregon, and colleagues conducted an economic evaluation of a mailed HPV self-sampling intervention among 19,851 underscreened (aged 30 to 64 years) enrolled in an integrated U.S. health care system who were randomly assigned to usual care (patient reminders and ad hoc outreach for screening) or usual care plus a mailed HPV self-sampling kit.

The researchers found that baseline incremental ratios ranged from $85.84 using wellness visits as the cost basis to $146.29 using Medicare Papanicolaou test-only visits as the cost source. Cost-effectiveness was achieved at lower levels of willingness to pay for an additional completed screening for subgroups of participants aged 50 to 64 years and participants most recently overdue for screening than for other subgroups.

"In this economic evaluation, mailing HPV self-sampling kits to women overdue for cervical cancer screening was cost-effective for increased screening uptake relative to usual care," the authors write. "These results support mailing HPV kits as an efficient outreach strategy for increasing among eligible women in U.S. health care systems."

More information: Richard T. Meenan et al, Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening, JAMA Network Open (2023). DOI: 10.1001/jamanetworkopen.2023.4052

Journal information: JAMA Network Open

Copyright © 2023 HealthDay. All rights reserved.

Citation: Mailed human papillomavirus self-sampling kits are cost-effective (2023, March 23) retrieved 3 June 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Cervical screening without a speculum boosts uptake among older patients


Feedback to editors